Back to trial details

Intake questionnaire

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Applying to Henry Ford Health · Detroit, Michigan

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 12 and 100 years old?
2. Have you been diagnosed with Systemic Lupus Erythematosus?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Detroit for study visits?